e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Immune aspects of asthma and other airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Coagulation activity increases with disease severity in patients with asthma
Marlous Sneeboer (Amsterdam, Netherlands), Marlous Sneeboer, Christof Majoor, Anne De Kievit, Joost Meijers, Rene Lutter, Tom Van der Poll, Pieter-Willem Kamphuisen, Peter Sterk, Elisabeth Bel
Source:
International Congress 2015 – Immune aspects of asthma and other airway diseases
Session:
Immune aspects of asthma and other airway diseases
Session type:
Thematic Poster Session
Number:
4016
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marlous Sneeboer (Amsterdam, Netherlands), Marlous Sneeboer, Christof Majoor, Anne De Kievit, Joost Meijers, Rene Lutter, Tom Van der Poll, Pieter-Willem Kamphuisen, Peter Sterk, Elisabeth Bel. Coagulation activity increases with disease severity in patients with asthma. Eur Respir J 2015; 46: Suppl. 59, 4016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Relation of hemogram parameters with asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Obesity influences inflammatory phenotype mainly in early onset severe asthmatics
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Systemic inflammation, comorbidities and the outcome of adult-onset asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Factors associated with irreversible airway obstruction in patients with asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Lung function impairment in adult asthma increases the risk of systemic inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Functional and immunological abnormalities in patients with severe asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
The temporal stability of coagulation and fibrinolytic factors in patients with asthma and healthy subjects
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Associated factors with persistent airflow limitation in asthma in U-BIOPRED
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Study the role of eNO-synthasegene polymorphism in patients with asthma and obesity
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Biomarkers of obesity associated with severe atopic asthma
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Higher burden of asthma symptoms and increased blood eosinophils in ACOS
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Systemic coagulation increases with asthma severity
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept